This has included thrombocytopenia, neutropenia, and even a decline in hemoglobin, all of which reversed on completion of treatment.19, , -22 In most cases, transfusions were not required, although there did appear to be a dose-response relationship with the amount of IL-2 administered and the decrease in blood counts. This evidence concerns the gene IL2 and neutropenia.